Tel Aviv University, Israel, develops genome editing system to destroy cancer cells Posted by: Admin December 17, 2020 in PR Comments Off on Tel Aviv University, Israel, develops genome editing system to destroy cancer cells
Using the Nobel Prize in Chemistry 2020 winning method, of genome editingCRISPR/Cas9, a research team atTel Aviv University has developed a breakthrough treatment to eliminate cancer cells.The treatment has no side effects andmay increase life expectancy in brain and ovarian cancer patients.
Link: https://www.youtube.com/watch?v=Mmar45X2oS8&feature=emb logo
In a recent study, researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers- a significant step on the way to finding a cure for cancer. Funded by ICRF (Israel Cancer Research Fund), the results of the groundbreaking study, were published in November 2020 in Science Advances.
Israel Cancer Research Fund announces 2020-2021 research grants
NEW YORK, N.Y.–Israel Cancer Research Fund ( ICRF) has announced funding for 69 cancer research grants, valued at $4,711,335, that will be supported for the 2020-2021 funding year.
The new grants include: the first Career Development Award (CDA) for a young clinician-scientist, co-funded with Conquer Cancer (The ASCO Foundation), as well as two new International Collaboration Grants for an Israeli scientist partnering with a U.S.-based scientist, co-funded with The Samuel Waxman Cancer Research Foundation and The Alan B. Slifka Foundation, and two new Gesher Grants for Israeli scientists returning to Israel after studying abroad, co-funded by ICRF Israel and The Israel Ministry of Science and Technology (MOST).